Evaxion Biotech stock hits 52-week low at $2.38 amid market challenges
In a turbulent period for biotech firms, Evaxion Biotech AS (EVAX) has seen its stock price plummet to $2.38, though InvestingPro analysis suggests the stock may be undervalued. According to ...
Jim Cramer on Pfizer Inc. (PFE): ‘It’s Too Low To Sell’
We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...
AI can boost efficacy of cancer treatment, but doctors remain key
A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of ...
Khosla Ventures Backs U.K. Startup’s Plan to Bring Cancer AI Tool to U.S.
C the Signs is using AI to sharpen predictions on cancer risk.
pancan14h
ABOUT Pancreatic Cancer
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.